Abstract
This study investigated the identification, antimicrobial resistance patterns, and phenotypic and genotypic traits of 30 Klebsiella isolates recovered from diverse animal species and infection sites. MALDI-TOF MS demonstrated higher accuracy in species-level identification than conventional phenotypic approaches, revealing a predominance of Klebsiella pneumoniae (80%), followed by K. variicola, K. aerogenes, and K. oxytoca. Multidrug resistance was detected in 46.6% of isolates, while 43.3% were extended-spectrum β-lactamase (ESBL) producers carrying genes such as blaTEM, blaCTX, and blaSHV. One carbapenemase-producing isolate was confirmed, and carbapenemase-encoding genes (blaOXA-48, blaNDM, blaKPC) were identified in additional strains. Notably, hypermucoviscosity was observed in four isolates, including the first report of a hypermucoviscous K. variicola from a dog. These findings highlight the presence of antimicrobial-resistant Klebsiella isolates in animal sources and support the need for integrated One Health surveillance.
Keywords: blaTEM, blaCTX, blaSHV, blaKPC, blaNDM, blaOXA-48
Introduction
Members of the order Enterobacterales—notably the genus Klebsiella—are frequent etiologic agents of veterinary infections, including urinary and respiratory tract disease, septicemia, and opportunistic nosocomial infections. Therapeutic management commonly relies on advanced β-lactams (third- and fourth-generation cephalosporins), β-lactam/β-lactamase inhibitor combinations, fluoroquinolones, aminoglycosides, and, in refractory cases, carbapenems.
Over recent decades, the global rise of antimicrobial resistance (AMR) has critically undermined these options. In particular, extended-spectrum β-lactamase (ESBL) producers and carbapenemase-producing Enterobacteriaceae have been prioritized by the World Health Organization due to their clinical impact and capacity for rapid dissemination. The selection and spread of resistance determinants are driven by antimicrobial misuse across human, animal, and environmental settings, reinforcing the need for integrated surveillance strategies under a One Health framework.
Within this context, multidrug-resistant (MDR) Klebsiella spp. have emerged across humans, companion animals, livestock, and wildlife, raising concerns regarding interspecies transmission and environmental persistence. MDR was defined as resistance to at least one agent in three or more antimicrobial classes [13]. Accurate species identification is essential for epidemiological investigation and infection control, however, conventional biochemical methods may misclassify closely related taxa such as K. pneumoniae vs. K. variicola. Proteomic identification using MALDI-TOF MS, combined with molecular approaches, has significantly improved taxonomic resolution and diagnostic accuracy.
A further layer of concern is the hypermucoviscosity phenotype described in some Klebsiella isolates, which has been associated with increased capsule production and may contribute to enhanced pathogenic potential. However, it is important to emphasize that hypermucoviscosity alone is not sufficient to define a hypervirulent phenotype, which typically requires the presence of specific virulence-associated genes or genomic confirmation.
This study aimed to characterize Klebsiella isolates recovered from clinical samples of domestic and wild animals by: (i) refining species identification using MALDI-TOF MS, (ii) determining phenotypic antimicrobial susceptibility profiles and MDR patterns, (iii) detecting ESBL- and carbapenemase-associated genes, and (iv) assessing the hypermucoviscosity phenotype. We hypothesized that Klebsiella isolates from animal sources may harbor clinically relevant antimicrobial resistance determinants and phenotypic traits associated with increased pathogenic potential, although no direct inference of hypervirulence was assumed.
Methodology
Sampling
Thirty isolates previously identified as Klebsiella spp. at the Veterinary Microbiological Diagnostic Laboratory (IV-UFRRJ) and at a private diagnostic laboratory, between 2017 and 2020, were included in this study. The isolates originated from a variety of domestic and wild animal species and were obtained from different clinical sites, including otic, uterine, choanal, and respiratory swabs, as well as skin, urine, lung tissue, and prostatic fluid (CEUA 9378290622). A convenience sampling strategy was employed, including all available Klebsiella isolates during the study period, which represents a limitation regarding representativeness.
Identification. Isolates were cultured on MacConkey agar and incubated at 35 °C ± 2 °C for 24 h. Colonies presenting typical morphology (pink, shiny, and in some cases mucoid) were selected. Preliminary identification was performed using Gram staining, 3% potassium hydroxide (KOH) testing, and conventional biochemical methods [11], prior to confirmatory analyses.
Proteomic identification by MALDI-TOF MS
Species confirmation was performed using MALDI-TOF MS at the Institute of Pharmacology and Molecular Biology (INFAR, EPM/UNIFESP). Isolates were cultured on CLED agar under standardized conditions. Sample preparation followed the formic acid extraction protocol, and spectra were acquired using a Microflex LT mass spectrometer (Bruker Daltonics) operating with a 337 nm nitrogen laser in linear mode. Spectra were collected within the 2,000–20,000 m/z range and analyzed using MALDI Biotyper software (version 2.0, Bruker), with identification based on comparison against the manufacturer’s reference database. Identification scores ranged from 0 to 3, with values ≥ 2.0 considered reliable for genus-level identification and higher scores indicating increased confidence at the species level. Quality control procedures were conducted according to manufacturer recommendations.
Antimicrobial resistance disk diffusion tests
All isolates underwent phenotypic resistance testing by the disk diffusion method on Mueller-Hinton agar, according to CLSI VET (2022) and BrCAST (2022) protocols. Antimicrobials were selected for evaluation of multidrug resistance (MDR), extended-spectrum beta-lactamase (ESBL) production, and carbapenemase production. MDR: Amoxicillin-clavulanic acid (30 µg) (Penicillins), Aztreonam (30 µg) (Monobactams), Cefepime (30 µg), Cefotaxime (30 µg), Ceftriaxone (30 µg), Ceftazidime (30 µg) (Cephalosporins), Eenrofloxacin (5 µg), Marbofloxacin (5 µg) (Fluoroquinolones), Gentamicin (10 µg) (Aminoglycosides), Sulfamethoxazole-trimethoprim (25 µg) (Sulfonamides), and Tetracycline (30 µg) (Tetracyclines). ESBL: Cefotaxime (30 µg), Ceftriaxone (30 µg), Ceftazidime (30 µg), and Aztreonam (30 µg). Carbapenemase: Meropenem (10 µg).
ESBL detection
Screening for ESBL production was performed using third-generation cephalosporins and aztreonam. Confirmatory testing was conducted using the combined disk method with clavulanic acid, and interpretation followed CLSI VET [1] criteria.
Carbapenemase enzyme detection (Carba NP Test)
For the test, isolates were subcultured on 5% sheep blood agar and incubated at 35 °C ± 2 °C for 24 h. Using a calibrated loop (10 µl), a bacterial inoculum was added to a microtube containing 5 M NaCl and vortexed for 1 min, then kept at room temperature for 30 min. A 100 µl solution containing Carba NP + imipenem + phenol red was added to each tube and incubated at 35 °C ± 2 °C for 2 h. Readings were taken at 15 min, 1 h, and 2 h. A positive result was indicated by a yellow/orange color, while a negative result retained the red color [1, 4].
Hypermucoviscosity phenotype test
Isolates were subcultured on MacConkey Agar and incubated at 35 °C ± 2 °C for 24 h. A sterile pipette tip was touched to the colony to observe the formation of a viscous string. The hypermucoviscosity phenotype was confirmed when the stretched string measured more than 5 mm ([5] adapted).
Genotypic detection of ESBL and Carbapenemase
For ESBL detection, the genes blaTEM [14], blaCTX-M [8], and blaSHV [17] were investigated. For carbapenemase detection, the genes blaKPC, blaNDM and blaOXA-48 were investigated in multiplex PCR [15] (Table 1).
Table 1.
Primers used in the characterization of antimicrobial resistance
| Gene | Primer | Cicle |
|---|---|---|
|
bla TEM (831 pb) |
ATGAGTATTCAACATTTCCGTG TTACCAATGCTTAATCAGTGAG |
94 °C for 5 min; 40 cycles (94 °C for 1 min, 55 °C for 1 min and 72 °C for 1 min) and final extension for 72 °C for 5 min. |
|
blaCTX (862 pb) |
AAAAATCACTGCGCCAGTTC CCGTCGGTGACGATTTTAGCC |
|
|
bla SHV (831 pb) |
TTTATCGGCCCTCACTCAAGG TTACCAATGCTTAATCAGTGAG |
94 °C for 3 min; 32 cycles (94 °C for 30 seg, 56 °C for 30 seg and 72 °C for 1 min) and final extension for 72 °C for 10 min. |
Statistic
Descriptive statistics were used to summarize the data. Proportions were calculated for resistance profiles and phenotypic traits.
Results and discussion
Origin of Isolates
Of the 30 Klebsiella isolates analyzed, 83.3% (25/30) were originally identified at the Veterinary Microbiological Diagnostic Laboratory of IV-UFRRJ, while 16.6% (5/30) were obtained from a private diagnostic facility. The majority (60%, 18/30) were isolated from dogs, followed by cats (23.3%, 7/30), birds (6.6%, 2/30), rabbit (3.3%, 1/30), cattle (3.3%, 1/30), and crab-eating raccoon (Procyon cancrivorus) (3.3%, 1/30). With respect to infection sites, urinary tract samples were the most frequent source (53.3%, 16/30), particularly from dogs (11/16). Other sources included the uterus (13.3%, 4/30), skin (10%, 3/30), respiratory tract (10%, 3/30), ears (10%, 3/30), prostate (3.3%, 1/30), and rectal mucosa (3.3%, 1/30).
These findings corroborate earlier reports highlighting Klebsiella as a common etiological agent of urinary tract infections in dogs [12, 18]. The predominance of urinary isolates emphasizes the role of Klebsiella in canine urogenital infections, while sporadic cases in wildlife underscore the potential for broader ecological dissemination.
Species Identification
Phenotypic biochemical methods frequently misclassified isolates, with discrepancies observed in 8/30 cases. In contrast, MALDI-TOF MS provided more accurate identification, confirming K. pneumoniae as the predominant species (80%, 24/30), followed by K. variicola (13.3%, 4/30), K. aerogenes (3.3%, 1/30), and K. oxytoca (3.3%, 1/30). All isolates yielded high-confidence genus-level scores (> 2,000), with nearly half (46.6%) achieving highly probable species-level identification.
The misidentification of K. variicola as K. pneumoniae, documented in previous studies [6, 16], was also observed here. This reinforces the superiority of proteomic methods, which remain crucial for distinguishing closely related Klebsiella species in veterinary diagnostics. All isolates scored above 2,000, indicating high reliability for genus-level identification of Klebsiella, according to established criteria (Table 2).
Table 2.
Relationship of isolates with the site of infection, animal species involved, phenotypic identification, proteomic identification and Score
| Strain | Infeccion site | Animal | Phenotipic | Proteomic | Score |
|---|---|---|---|---|---|
| 01 | Ear | Dog | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.103 (++) |
| 02 | Urinary tract | Dog | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.388 (+++) |
| 03 | Urinary tract | Dog | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.185 (++) |
| 04 | Urinary tract | Dog | Klebsiella pneumoniae | Klebsiella variicola | 2.243 (++) |
| 05 | Skin | Cat | Klebsiella aerogenes | Klebsiella variicola | 2.365 (+++) |
| 06 | Urinary tract | Dog | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.206 (++) |
| 07 | Urinary tract | Dog | Klebsiella aerogenes | Klebsiella pneumoniae | 2.287 (++) |
| 09 | Ear | Dog | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.293 (++) |
| 10 | Prostate | Dog | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.405 (+++) |
| 14 | Urinary tract | Dog | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.314 (+++) |
| 15 | Urinary tract | Dog | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.387 (+++) |
| 16 | Urinary tract | Cat | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.145 (++) |
| 17 | Respiratory tract | Macaw | Klebsiella pneumoniae | Klebsiella variicola | 2.146 (++) |
| 18 | Skin | Cat | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.315 (+++) |
| 19 | Urinary tract | Cat | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.240 (++) |
| 20 | Urinary tract | Cat | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.020 (++) |
| 22 | Uterus | Dog | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.379 (+++) |
| 25 | Respiratory tract | Rabbit | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.477 (+++) |
| 26 | Uterus | Dog | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.387 (+++) |
| 27 | Urinary tract | Dog | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.392 (+++) |
| 28 | Respiratory tract | Cow | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.297 (++) |
| 29 | Uterus | Dog | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.051 (++) |
| 31 | Urinary tract | Dog | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.406 (+++) |
| 32 | Urinary tract | Cat | Klebsiella pneumoniae | Klebsiella oxytoca | 2.244 (++) |
| 33 | Urinary tract | Dog | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.424 (+++) |
| 39 | Urinary tract | Cat | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.145 (++) |
| 40 | Urinary tract | Dog | Klebsiella oxytoca | Klebsiella pneumoniae | 2.265 (++) |
| 41 | Uterus | Dog | Klebsiella pneumoniae | Klebsiella variicola | 2.143 (++) |
| 42 | Rectum | Crested caracara | Klebsiella pneumoniae | Klebsiella aerogenes | 2.434 (+++) |
| 44 | Skin | caracara | Klebsiella pneumoniae | Klebsiella pneumoniae | 2.367 (+++) |
Among the 24 Klebsiella pneumoniae isolates, infection sites were distributed as follows: urinary tract, 58.3%; uterus, 12.5%; ear, 8.3%; respiratory tract, 8.3%; dermatologic sites, 8.3%; and prostate, 4.1% (Table 3).
Table 3.
Number of Klebsiella spp. isolates according to the site of infection
| Klebsiella pneumoniae | Klebsiella variicola | Klebsiella aerogenes | Klebsiella oxytoca | |
|---|---|---|---|---|
| Urinary tract | 14 | 1 | 0 | 1 |
| Uterus | 3 | 1 | 0 | 0 |
| Skin | 2 | 1 | 0 | 0 |
| Respiratory tract | 2 | 1 | 0 | 0 |
| Ear | 2 | 0 | 0 | 0 |
| Rectum | 0 | 0 | 1 | 0 |
| Prostate | 1 | 0 | 0 | 0 |
| Total | 24 | 4 | 1 | 1 |
Antimicrobial resistance profiles
Disk diffusion testing revealed that 46.6% (14/30) of isolates were multidrug-resistant (MDR), with resistance to three or more antimicrobial classes. Resistance rates were particularly high against third-generation cephalosporins: cefotaxime (66.6%), ceftazidime (63.3%), and ceftriaxone (53.3%). Notably, one isolate exhibited carbapenem resistance (3.3%).
Screening for extended-spectrum β-lactamase (ESBL) production identified 83.3% (25/30) as potential ESBL producers. Confirmatory testing demonstrated that 43.3% (13/30) met CLSI VET (2022) criteria for ESBL production. Molecular analysis further revealed that 60% (15/25) of screening-positive isolates harbored ESBL-encoding genes: blaTEM (66.7%), blaCTX (26.7%), and blaSHV (6.6%).
These data align with prior studies in domestic animals across Europe, Asia, and South America, which have reported escalating rates of MDR and ESBL-producing K. pneumoniae [3, 10, 19]. The rising prevalence observed here reflects a growing threat within veterinary contexts and reinforces concerns over the zoonotic potential of ESBL-producing Klebsiella.
Carbapenemase-producing strains
The adapted Carba NP test confirmed one carbapenemase-producing Klebsiella pneumoniae isolate recovered from canine urine, which also exhibited multidrug-resistant (MDR) and extended-spectrum β-lactamase (ESBL) phenotypes. In addition, six isolates were found to carry carbapenemase-encoding genes, including blaOXA-48 (50%), blaNDM (33.3%), and blaKPC (16.7%). Notably, two isolates simultaneously harbored blaCTX and blaOXA-48.
A discrepancy was observed between the genotypic detection of carbapenemase genes and the phenotypic confirmation of carbapenemase production, as only one isolate was confirmed by the Carba NP test. This finding may be explained by several factors, including variable or low-level gene expression, the presence of non-functional or truncated genes, and differences in regulatory mechanisms affecting enzyme production. In addition, phenotypic assays such as the Carba NP test may have limited sensitivity for detecting certain carbapenemases, particularly OXA-48-like enzymes, which are known to confer weak hydrolytic activity and may result in borderline or negative phenotypic results.
It is also important to consider that the mere presence of resistance genes does not necessarily translate into clinically relevant resistance, as gene expression, bacterial fitness costs, and permeability factors (such as porin loss or efflux pump activity) can influence the phenotypic outcome. Therefore, the detection of carbapenemase genes should be interpreted with caution, particularly in the absence of complementary molecular or functional analyses.
Although reports of carbapenem-resistant Klebsiella spp. in veterinary medicine remain limited, their detection is of concern given the critical importance of carbapenems as last-resort antimicrobials in human medicine. Similar findings reported in Europe, Asia, and Africa [9, 20] suggest the potential for global dissemination of these resistance determinants. However, due to the lack of additional molecular characterization in the present study, including plasmid analysis or whole genome sequencing, it is not possible to determine the genetic context or transmission dynamics of the detected genes, which represents an important limitation to be addressed in future investigations (Table 4).
Table 4.
Number of Klebsiella spp. isolates that exhibited resistance according to the disk diffusion antibiogram
| Antimicrobial | Strains | Percentage |
|---|---|---|
| Amoxicilin+ Clavulanic acid | 14 | 46,6% |
| Aztreonam | 19 | 63,3% |
| Cefepim | 15 | 50% |
| Cefotaxim | 20 | 66,6% |
| Ceftriaxone | 16 | 53,3% |
| Ceftazidime | 19 | 63,3% |
| enrofloxacin | 13 | 43,3% |
| Gentamicin | 14 | 46,6% |
| Marbofloxacine | 9 | 30% |
| Meropenem | 1 | 3,3% |
| Sulfametoxazol-Trimetoprime | 11 | 36,6% |
| Tetracicline | 12 | 40% |
Hypermucoviscosity phenotype
Four isolates (13.3%) tested positive for the hypermucoviscosity (Hmv) phenotype, including three Klebsiella pneumoniae isolates from canine urinary tract infections and one Klebsiella variicola isolate recovered from a uterine infection in a dog diagnosed with pyometra. Notably, two of these Hmv-positive isolates also exhibited multidrug-resistant (MDR) and extended-spectrum β-lactamase (ESBL) phenotypes, suggesting a concerning overlap between resistance and phenotypic traits potentially associated with increased virulence.
The identification of a hypermucoviscous K. variicola isolate in an animal host represents, to our knowledge, the first report in veterinary medicine. Previous studies describing Hmv-positive K. variicola have been limited to human clinical settings [2, 7], which highlights the potential expansion of this phenotype across hosts and reinforces its relevance within a One Health perspective. However, it is important to emphasize that the hypermucoviscosity phenotype alone is not sufficient to classify isolates as hypervirulent. The absence of molecular characterization targeting virulence-associated genes, such as rmpA, rmpA2, iucA, or iroB, as well as the lack of whole genome sequencing, limits the ability to establish a definitive link between the observed phenotype and hypervirulence.
Furthermore, the coexistence of hypermucoviscosity with MDR and ESBL phenotypes in some isolates may represent a clinically relevant combination, potentially impacting treatment outcomes. Nevertheless, this association should be interpreted with caution, as the genetic basis and expression of both virulence and resistance determinants were not investigated in depth in this study. Additional molecular analyses are required to clarify whether these traits are co-located on mobile genetic elements, such as plasmids, or represent independent characteristics. Overall, these findings underscore the need for further genomic and functional studies to better understand the clinical and epidemiological significance of hypermucoviscous Klebsiella spp. in veterinary contexts.
One health implications
This study demonstrates the co-occurrence of MDR, ESBL production, carbapenemase-associated genes, and the hypermucoviscosity phenotype in Klebsiella isolates from diverse animal species. The findings suggest that companion animals may harbor clinically relevant Klebsiella isolates with resistance determinants of veterinary and public health interest. The data highlight the necessity of continuous surveillance, molecular monitoring, and integrated One Health strategies to mitigate the dissemination of these pathogens and safeguard antimicrobial efficacy.
Conclusion
MALDI-TOF MS outperformed conventional phenotypic methods for species-level identification of veterinary Klebsiella, revealing a predominance of K. pneumoniae and the presence of K. variicola. Nearly half of the isolates were multidrug-resistant, 43.3% produced ESBLs, and carbapenemase determinants (blaOXA-48, blaNDM, blaKPC) were detected, underscoring the presence of important resistance mechanisms in animal isolates.
Hypermucoviscosity was identified in four isolates, including the first report of hypermucoviscous K. variicola from a dog. However, because hypermucoviscosity alone does not confirm hypervirulence, further studies including virulence-associated gene detection and genomic analyses are needed to clarify the clinical significance of these isolates.
Future investigations will build upon these findings by expanding sample collection to a broader, multicenter framework, enabling a more comprehensive assessment of the epidemiological distribution of Klebsiella spp. Additionally, the application of whole-genome sequencing will provide deeper insights into clonal relationships, resistance determinants, and virulence profiles, contributing to a more detailed understanding of the genetic and epidemiological dynamics of these isolates.
Acknowledgements
This study received support from the Carlos Chagas Foundation for Research Support of the State of Rio de Janeiro (FAPERJ, E-26/210.085/2020, E-26/211.554/2019 and E-26/202.604/2019), the Coordination for the Improvement of Higher Education Personnel (CAPES), Technological Development (CNPq) and the Foundation for Scientific and Technological Research Support of UFRRJ (FAPUR).
Funding
The Article Processing Charge (APC) for the publication of this research was funded by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) (ROR identifier: 00x0ma614).
Declarations
Competing interests
The authors declare that they have no competing interests to report.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.CLSI. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals (2023) CLSI supplement VET01S, 6th ed. Clinical and Laboratory Standards Institute, Wayne (PA)
- 2.De Campos T et al (2021) Multidrug-resistant Klebsiella variicola strains isolated in a Brazilian hospital belong to new clones. Front Microbiol 12:604031. 10.3389/fmicb.2021.604031 [DOI] [PMC free article] [PubMed]
- 3.Donati V, Feltrin F, Hendriksen RS et al (2014) Extended-spectrum β-lactamases, AmpC β-lactamases and plasmid-mediated quinolone resistance in Klebsiella spp. from companion animals in Italy. PLoS ONE 9(3):e90564 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Dortet L, Poirel L, Nordmann P (2014) Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test. J Med Microbiol 63:772–776 [DOI] [PubMed]
- 5.Fang C et al (2004) A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J Exp Med 199(5):697–705 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Fontana L et al (2019) The brief case: Klebsiella variicola—identifying the misidentified. J Clin Microbiol 57(1):e01106–e01118 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Garza-Ramos U et al (2015) Draft genome sequence of the first hypermucoviscous Klebsiella variicola clinical isolate. Genome Announc 3(2):e00060–e00015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Geser N, Stephan R, Hächler H (2012) Occurrence and characteristics of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae in food-producing animals, minced meat and raw milk. BMC Vet Res 8:21 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Hamza E, Dorgham SM, Hamza DA (2016) Carbapenemase-producing Klebsiella pneumoniae in broiler poultry farming in Egypt. J Glob Antimicrob Resist 7:8–10 [DOI] [PubMed]
- 10.Harada K et al (2016) Phenotypic and molecular characterization of antimicrobial resistance in Klebsiella spp. isolates from companion animals in Japan: clonal dissemination of multidrug-resistant ESBL-producing Klebsiella pneumoniae. Front Microbiol 7:1021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Koneman EW et al (2006) Diagnóstico Microbiológico: Texto e Atlas Colorido, 6th edn. Guanabara Koogan, Rio de Janeiro, p 1760 [Google Scholar]
- 12.Ling GV et al (2001) Interrelations of organism prevalence, specimen collection method, and host factors among 8,354 canine urinary tract infections (1969–1995). J Vet Intern Med 15(4):341–347 [PubMed] [Google Scholar]
- 13.Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268–281 [DOI] [PubMed]
- 14.Minarini LAR et al (2007) Prevalence of community-occurring extended-spectrum β-lactamase-producing Enterobacteriaceae in Brazil. Curr Microbiol 54:335–341 [DOI] [PubMed] [Google Scholar]
- 15.Monteiro J et al (2012) Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother 67(4):906–909 [DOI] [PubMed] [Google Scholar]
- 16.Podder MP et al (2014) Klebsiella species associated with bovine mastitis in Newfoundland. PLoS ONE 9(9):e106518 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Shahid M (2010) Citrobacter spp. simultaneously harboring blaCTX-M, blaTEM, blaSHV, blaampC, and insertion sequences IS26 and orf513: an evolutionary phenomenon of recent concern for antibiotic resistance. J Clin Microbiol 48:1833–1838 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Silva BGB et al (2025) Estudo retrospectivo da multirresistência microbiana em cistites e otites de cães e gatos. Braz J Anim Environ Res 8(2):e79542 [Google Scholar]
- 19.Sousa ATHI et al (2019) Perfil de resistência antimicrobiana de Klebsiella pneumoniae isoladas de animais domésticos e silvestres. Arquivo Brasileiro de Medicina Veterinária e Zootecnia 71(2):584–593
- 20.Stolle I et al (2013) Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs. J Antimicrob Chemother 68(12):2802–2808 [DOI] [PubMed] [Google Scholar]
Guidelines/online resources
- 21.BrCAST. Tabela de Pontos de Corte Clínicos BrCAST versão 05-2024 [Internet]. São Paulo: BrCAST; 2024 [cited 2025 May 1]. Available from: http://brcast.org.br/documentos/
- 22.BrCAST. Orientações do EUCAST para detecção de mecanismos de resistência de importância clínica e/ou epidemiológica. Versão 2.0 [Internet]. São Paulo: BrCAST; 2022 Sep [cited 2025 May 1]. Available from: http://brcast.org.br/documentos/
- 23.MSD Manual Professional. Infecções por Klebsiella, Enterobacter e Serratia—tratamento [Internet]. 2025 [cited 2025 Jul 18]. Available from: https://www.msdmanuals.com/pt/profissional/
- 24.Pan American Health Organization (PAHO). WHO publishes list of bacteria for which new antibiotics are urgently needed [Internet]. 2017 [cited 2025 May 1]. Available from: https://www.paho.org/
